Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Semaglutide , marketed under names like Wegovy and Ozempic, is a medication originally developed to manage type 2 diabetes
Treatment may help promote a refreshed and healthy-looking complexion
Triple-hormone-receptor agonist retatrutide for obesity A Phase 2 trial. New England Journal of Medicine
Efficacy and safety In clinical trials, individuals taking Ozempic have been shown to reduce 15-20 per cent of their body weight
Unlike previous generations of peptides that targeted only one or two hormonal pathways, Retatrutide introduces a revolutionary triple-action mechanism that targets GLP-1, GIP, and Glucagon receptors simultaneously
Written By: Pharmacally Medical News Desk Sun Pharmaceutical Industries Limited has received approval from the Drug Controller General of India (DCGI) to manufacture and market a generic version of semaglutide injection for chronic weight management in adults
